Intestinal Microbiome and Chronic Inflammatory Bowel Disease

Withdrawn

• Conditions: Colitis

• Registration Number: NCT02768038
• Lead Sponsor: Turku University Hospital

Brief Summary

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Detailed Description

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Study Timeline

• Study First Submitted: 2015-12-16
• Study Start: 2016-05-01
• Study First Submitted QC: 2016-05-10
• Study First Posted: 2016-05-11
• Primary Completion: 2020-12-01
• Study Completion: 2020-12-01
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-28
• Last Update Posted: 2025-05-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• IBD

Exclusion Criteria

• patient refusal to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change of microbiome in chronic inflammatory bowel disease	5 yrs

Trial Locations

Locations (1)

Turku University Hospital; 🇫🇮 Turku, Finland